Ignite Creation Date:
2025-12-25 @ 4:15 AM
Ignite Modification Date:
2026-03-12 @ 8:52 AM
Study NCT ID:
NCT05897320
Status:
RECRUITING
Last Update Posted:
2025-12-16
First Post:
2023-05-31
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study of Eptinezumab in Pediatric Participants With Episodic Migraine
Sponsor:
H. Lundbeck A/S
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2023-06-08
Start Date Type:
ACTUAL
Primary Completion Date:
2027-07-06
Primary Completion Date Type:
ESTIMATED
Completion Date:
2027-08-31
Completion Date Type:
ESTIMATED
First Submit Date:
2023-05-31
First Submit QC Date:
None
Study First Post Date:
2023-06-09
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-12-12
Last Update Post Date:
2025-12-16
Last Update Post Date Type:
ESTIMATED